222 related articles for article (PubMed ID: 12409653)
1. Proteasome inhibitors as new anticancer drugs.
Adams J
Curr Opin Oncol; 2002 Nov; 14(6):628-34. PubMed ID: 12409653
[TBL] [Abstract][Full Text] [Related]
2. Clinical update: proteasome inhibitors in solid tumors.
Lenz HJ
Cancer Treat Rev; 2003 May; 29 Suppl 1():41-8. PubMed ID: 12738242
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition: a novel approach to cancer therapy.
Adams J
Trends Mol Med; 2002; 8(4 Suppl):S49-54. PubMed ID: 11927288
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.
Giuliano M; D'Anneo A; De Blasio A; Vento R; Tesoriere G
Ital J Biochem; 2003 Jun; 52(2):112-21. PubMed ID: 14677428
[TBL] [Abstract][Full Text] [Related]
5. Development of the proteasome inhibitor Velcade (Bortezomib).
Adams J; Kauffman M
Cancer Invest; 2004; 22(2):304-11. PubMed ID: 15199612
[TBL] [Abstract][Full Text] [Related]
6. Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib.
Cusack JC
Cancer Treat Rev; 2003 May; 29 Suppl 1():21-31. PubMed ID: 12738240
[TBL] [Abstract][Full Text] [Related]
7. The proteasome: structure, function, and role in the cell.
Adams J
Cancer Treat Rev; 2003 May; 29 Suppl 1():3-9. PubMed ID: 12738238
[TBL] [Abstract][Full Text] [Related]
8. Potential for proteasome inhibition in the treatment of cancer.
Adams J
Drug Discov Today; 2003 Apr; 8(7):307-15. PubMed ID: 12654543
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition in cancer: development of PS-341.
Adams J
Semin Oncol; 2001 Dec; 28(6):613-9. PubMed ID: 11740819
[TBL] [Abstract][Full Text] [Related]
10. Clinical update: proteasome inhibitors in hematologic malignancies.
Richardson P
Cancer Treat Rev; 2003 May; 29 Suppl 1():33-9. PubMed ID: 12738241
[TBL] [Abstract][Full Text] [Related]
11. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.
Shah SA; Potter MW; McDade TP; Ricciardi R; Perugini RA; Elliott PJ; Adams J; Callery MP
J Cell Biochem; 2001 Apr 2-27; 82(1):110-22. PubMed ID: 11400168
[TBL] [Abstract][Full Text] [Related]
12. PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.
Ling YH; Liebes L; Ng B; Buckley M; Elliott PJ; Adams J; Jiang JD; Muggia FM; Perez-Soler R
Mol Cancer Ther; 2002 Aug; 1(10):841-9. PubMed ID: 12492117
[TBL] [Abstract][Full Text] [Related]
13. [Proteasome inhibitor].
Yamamura M; Hirai T; Yamaguchi Y
Nihon Rinsho; 2010 Jun; 68(6):1079-84. PubMed ID: 20535959
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathways that modify tumor radiation response.
Pervan M; Pajonk F; Sun JR; Withers HR; McBride WH
Am J Clin Oncol; 2001 Oct; 24(5):481-5. PubMed ID: 11586100
[TBL] [Abstract][Full Text] [Related]
15. [Proteasome inhibitor, bortezomib (Vercade), potently inhibits the growth of adult T-cell leukemia cells].
Satou Y; Matsuoka M
Nihon Rinsho; 2004 Jul; 62(7):1363-7. PubMed ID: 15283157
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
17. A review of the proteasome inhibitor bortezomib in multiple myeloma.
Richardson PG
Expert Opin Pharmacother; 2004 Jun; 5(6):1321-31. PubMed ID: 15163277
[TBL] [Abstract][Full Text] [Related]
18. Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Fanourakis G; Gu X; Bailey C; Joseph M; Libermann TA; Treon SP; Munshi NC; Richardson PG; Hideshima T; Anderson KC
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14374-9. PubMed ID: 12391322
[TBL] [Abstract][Full Text] [Related]
19. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
[TBL] [Abstract][Full Text] [Related]
20. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]